To overcome this, Forever Healthy's "Rejuvenation Now" initiative seeks to continuously identify rejuvenation therapies that are available right now and systematically evaluates them on their risks, benefits, procedures and potential application in order to create transparency regarding the current state of said therapies.
The first publication released by the initiative is a "Risk & Benefit Analysis of NAD+ Restoration Therapy", a systematic review of the published evidence. The team at Forever Healthy screened over 2000 publications resulting in the inclusion of more than 150 preclinical and 40 clinical trials on the use of oral NAD precursors, transdermal patches or infusions to raise NAD+ to youthful levels.
A second publication covering the intermittent use of high dose fisetin as a senolytic agent is already completed and under review by selected members of the rejuvenation community on the foundations RFC portal. It is expected to be released to the general public in the next weeks.
Future upcoming work of the initiative will amongst others cover topics such as the use of essential phospholipids to rejuvenate cell membranes and improve their condition, the use of low-level light therapy to rejuvenate the skin, and the use of EDTA to decalcify both arteries as well as the capillary system.